20 min listen
COVID-19 Update 13: How Pandemic Affects Labs & Early-Career Researchers, Drs. Michaelis & Levine
FromThe Hematologist
COVID-19 Update 13: How Pandemic Affects Labs & Early-Career Researchers, Drs. Michaelis & Levine
FromThe Hematologist
ratings:
Length:
18 minutes
Released:
Jun 23, 2020
Format:
Podcast episode
Description
In this installment, The Hematologist Editor-in-Chief Dr. Laura Michaelis has a conversation with Dr. Ross Levine of Memorial Sloan Kettering Cancer Center. They discuss the ASH COVID-19 Research Agenda for Hematology, steps for getting a lab back up and running, and the effects of the pandemic on early-career researchers. Find additional ASH resources available to help the hematology community be prepared and proactive during the COVID-19 public health crisis, by visiting www.hematology.org/COVID-19. If you have recommendations for topics to cover in this podcast series, please email us at thehematologist@hematology.org.While we regularly review and update the links, resources, and FAQs posted on the ASH website to reflect the best information available at a given point in time, the COVID-19 pandemic is a rapidly evolving global health crisis. Please take note of the dates of publication for each podcast.Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
Released:
Jun 23, 2020
Format:
Podcast episode
Titles in the series (100)
A Conversation about the TWiTCH Trial with Dr. Russell Ware and Dr. Michael DeBaun: In his Diffusion article from the March/April issue of The Hematologist, Dr. Michael DeBaun (Vanderbilt University School of Medicine) takes a look at the TWiTCH Trial, a multicenter, open-label, phase III, non-inferiority trial. Dr. Russell Ware (Univers by The Hematologist